Refanezumab (Anti-Siglec-4a / MAG)
Refanezumab (Anti-Siglec-4a / MAG) is an IgG1-type humanized monoclonal antibody directed against myelin-associated glycoprotein (MAG). Refanezumab binds to MAG and blocks MAG-mediated inhibition of axonal regeneration. MW : 145.5 KD
Supplier | Selleck Chemicals |
---|---|
Product # | A2356 |
Sku # | A2356-1mg*25 |
Pricing | 1mg*25, $5070.00 |